id sid tid token lemma pos dpc-2039 1 1 dermatology dermatology NOUN dpc-2039 1 2 : : PUNCT dpc-2039 1 3 practical practical ADJ dpc-2039 1 4 and and CCONJ dpc-2039 1 5 conceptual conceptual ADJ dpc-2039 1 6 image image NOUN dpc-2039 1 7 letter letter NOUN dpc-2039 2 1 | | ADV dpc-2039 2 2 dermatol dermatol ADJ dpc-2039 2 3 pract pract NOUN dpc-2039 2 4 concept concept NOUN dpc-2039 2 5 . . PUNCT dpc-2039 3 1 2022;12(4):e2022131 2022;12(4):e2022131 NUM dpc-2039 3 2 1 1 NUM dpc-2039 3 3 necrobiotic necrobiotic ADJ dpc-2039 3 4 xanthogranuloma xanthogranuloma NOUN dpc-2039 3 5 as as ADP dpc-2039 3 6 sign sign NOUN dpc-2039 3 7 of of ADP dpc-2039 3 8 monoclonal monoclonal NOUN dpc-2039 3 9 gammopathy gammopathy ADJ dpc-2039 3 10 claudio claudio NOUN dpc-2039 3 11 conforti1 conforti1 NOUN dpc-2039 3 12 , , PUNCT dpc-2039 3 13 iris iris NOUN dpc-2039 3 14 zalaudek1 zalaudek1 NOUN dpc-2039 3 15 1 1 NUM dpc-2039 3 16 dermatology dermatology NOUN dpc-2039 3 17 clinic clinic NOUN dpc-2039 3 18 , , PUNCT dpc-2039 3 19 maggiore maggiore NOUN dpc-2039 3 20 hospital hospital NOUN dpc-2039 3 21 , , PUNCT dpc-2039 3 22 piazza piazza VERB dpc-2039 3 23 dell’ospitale dell’ospitale ADJ dpc-2039 3 24 1 1 NUM dpc-2039 3 25 , , PUNCT dpc-2039 3 26 university university NOUN dpc-2039 3 27 of of ADP dpc-2039 3 28 trieste trieste PROPN dpc-2039 3 29 , , PUNCT dpc-2039 3 30 trieste trieste PROPN dpc-2039 3 31 , , PUNCT dpc-2039 3 32 italy italy PROPN dpc-2039 3 33 citation citation PROPN dpc-2039 3 34 : : PUNCT dpc-2039 3 35 conforti conforti PROPN dpc-2039 4 1 c c PROPN dpc-2039 4 2 , , PUNCT dpc-2039 4 3 zalaudek zalaudek PROPN dpc-2039 4 4 i. i. PROPN dpc-2039 4 5 necrobiotic necrobiotic PROPN dpc-2039 4 6 xanthogranuloma xanthogranuloma PROPN dpc-2039 4 7 as as ADP dpc-2039 4 8 sign sign NOUN dpc-2039 4 9 of of ADP dpc-2039 4 10 monoclonal monoclonal NOUN dpc-2039 4 11 gammopathy gammopathy ADJ dpc-2039 4 12 . . PUNCT dpc-2039 5 1 dermatol dermatol NOUN dpc-2039 5 2 pract pract PROPN dpc-2039 5 3 concept concept NOUN dpc-2039 5 4 . . PUNCT dpc-2039 6 1 2022;12(4):e2022131 2022;12(4):e2022131 X dpc-2039 6 2 . . PUNCT dpc-2039 6 3 doi doi PROPN dpc-2039 6 4 : : PUNCT dpc-2039 6 5 https://doi.org/10.5826/dpc.1204a131 https://doi.org/10.5826/dpc.1204a131 NOUN dpc-2039 6 6 accepted accept VERB dpc-2039 6 7 : : PUNCT dpc-2039 6 8 january january PROPN dpc-2039 6 9 9 9 NUM dpc-2039 6 10 , , PUNCT dpc-2039 6 11 2022 2022 NUM dpc-2039 6 12 ; ; PUNCT dpc-2039 6 13 published publish VERB dpc-2039 6 14 : : PUNCT dpc-2039 6 15 october october PROPN dpc-2039 6 16 2022 2022 NUM dpc-2039 7 1 copyright copyright NOUN dpc-2039 7 2 : : PUNCT dpc-2039 7 3 © © PROPN dpc-2039 7 4 2022 2022 NUM dpc-2039 7 5 conforti conforti PROPN dpc-2039 7 6 et et PROPN dpc-2039 7 7 al al PROPN dpc-2039 7 8 . . PUNCT dpc-2039 8 1 this this PRON dpc-2039 8 2 is be AUX dpc-2039 8 3 an an DET dpc-2039 8 4 open open ADJ dpc-2039 8 5 - - PUNCT dpc-2039 8 6 access access NOUN dpc-2039 8 7 article article NOUN dpc-2039 8 8 distributed distribute VERB dpc-2039 8 9 under under ADP dpc-2039 8 10 the the DET dpc-2039 8 11 terms term NOUN dpc-2039 8 12 of of ADP dpc-2039 8 13 the the DET dpc-2039 8 14 creative creative ADJ dpc-2039 8 15 commons common NOUN dpc-2039 8 16 attribution attribution NOUN dpc-2039 8 17 - - PUNCT dpc-2039 8 18 noncommercial noncommercial ADJ dpc-2039 8 19 license license NOUN dpc-2039 8 20 ( ( PUNCT dpc-2039 8 21 by by ADP dpc-2039 8 22 - - PUNCT dpc-2039 8 23 nc-4.0 nc-4.0 NOUN dpc-2039 8 24 ) ) PUNCT dpc-2039 8 25 , , PUNCT dpc-2039 8 26 https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ PROPN dpc-2039 8 27 , , PUNCT dpc-2039 8 28 which which PRON dpc-2039 8 29 permits permit VERB dpc-2039 8 30 unrestricted unrestricted ADJ dpc-2039 8 31 noncommercial noncommercial ADJ dpc-2039 8 32 use use NOUN dpc-2039 8 33 , , PUNCT dpc-2039 8 34 distribution distribution NOUN dpc-2039 8 35 , , PUNCT dpc-2039 8 36 and and CCONJ dpc-2039 8 37 reproduction reproduction NOUN dpc-2039 8 38 in in ADP dpc-2039 8 39 any any DET dpc-2039 8 40 medium medium NOUN dpc-2039 8 41 , , PUNCT dpc-2039 8 42 provided provide VERB dpc-2039 8 43 the the DET dpc-2039 8 44 original original ADJ dpc-2039 8 45 authors author NOUN dpc-2039 8 46 and and CCONJ dpc-2039 8 47 source source NOUN dpc-2039 8 48 are be AUX dpc-2039 8 49 credited credit VERB dpc-2039 8 50 . . PUNCT dpc-2039 9 1 funding funding NOUN dpc-2039 9 2 : : PUNCT dpc-2039 9 3 none none NOUN dpc-2039 9 4 . . PUNCT dpc-2039 10 1 competing compete VERB dpc-2039 10 2 interests interest NOUN dpc-2039 10 3 : : PUNCT dpc-2039 10 4 none none NOUN dpc-2039 10 5 . . PUNCT dpc-2039 11 1 authorship authorship NOUN dpc-2039 11 2 : : PUNCT dpc-2039 11 3 all all DET dpc-2039 11 4 authors author NOUN dpc-2039 11 5 have have AUX dpc-2039 11 6 contributed contribute VERB dpc-2039 11 7 significantly significantly ADV dpc-2039 11 8 to to ADP dpc-2039 11 9 this this DET dpc-2039 11 10 publication publication NOUN dpc-2039 11 11 . . PUNCT dpc-2039 12 1 corresponding correspond VERB dpc-2039 12 2 author author NOUN dpc-2039 12 3 : : PUNCT dpc-2039 12 4 claudio claudio PROPN dpc-2039 12 5 conforti conforti PROPN dpc-2039 12 6 , , PUNCT dpc-2039 12 7 md md PROPN dpc-2039 12 8 , , PUNCT dpc-2039 12 9 dermatology dermatology NOUN dpc-2039 12 10 clinic clinic NOUN dpc-2039 12 11 , , PUNCT dpc-2039 12 12 hospital hospital NOUN dpc-2039 12 13 maggiore maggiore NOUN dpc-2039 12 14 , , PUNCT dpc-2039 12 15 trieste trieste PROPN dpc-2039 12 16 , , PUNCT dpc-2039 12 17 italy italy PROPN dpc-2039 12 18 . . PUNCT dpc-2039 13 1 phone phone NOUN dpc-2039 13 2 number number NOUN dpc-2039 13 3 : : PUNCT dpc-2039 13 4 +39 +39 PROPN dpc-2039 13 5 3335441549 3335441549 NUM dpc-2039 13 6 , , PUNCT dpc-2039 13 7 e e NOUN dpc-2039 13 8 - - NOUN dpc-2039 13 9 mail mail NOUN dpc-2039 13 10 address address NOUN dpc-2039 13 11 : : PUNCT dpc-2039 14 1 claudioconforti@yahoo.com claudioconforti@yahoo.com X dpc-2039 14 2 case case NOUN dpc-2039 14 3 presentation presentation NOUN dpc-2039 14 4 a a DET dpc-2039 14 5 52 52 NUM dpc-2039 14 6 - - PUNCT dpc-2039 14 7 year year NOUN dpc-2039 14 8 - - PUNCT dpc-2039 14 9 old old ADJ dpc-2039 14 10 woman woman NOUN dpc-2039 14 11 referred refer VERB dpc-2039 14 12 to to ADP dpc-2039 14 13 our our PRON dpc-2039 14 14 skin skin NOUN dpc-2039 14 15 cancer cancer NOUN dpc-2039 14 16 unit unit NOUN dpc-2039 14 17 for for ADP dpc-2039 14 18 the the DET dpc-2039 14 19 presence presence NOUN dpc-2039 14 20 of of ADP dpc-2039 14 21 yellow yellow ADJ dpc-2039 14 22 periorbital periorbital ADJ dpc-2039 14 23 plaques plaque NOUN dpc-2039 14 24 that that PRON dpc-2039 14 25 enlarged enlarge VERB dpc-2039 14 26 over over ADP dpc-2039 14 27 the the DET dpc-2039 14 28 past past ADJ dpc-2039 14 29 decade decade NOUN dpc-2039 14 30 . . PUNCT dpc-2039 14 31     SPACE dpc-2039 15 1 based base VERB dpc-2039 15 2 on on ADP dpc-2039 15 3 the the DET dpc-2039 15 4 clinical clinical ADJ dpc-2039 15 5 and and CCONJ dpc-2039 15 6 dermoscopic dermoscopic ADJ dpc-2039 15 7 presentations presentation NOUN dpc-2039 15 8 ( ( PUNCT dpc-2039 15 9 figure figure NOUN dpc-2039 15 10 1 1 NUM dpc-2039 15 11 ) ) PUNCT dpc-2039 15 12 , , PUNCT dpc-2039 15 13 a a DET dpc-2039 15 14 clinical clinical ADJ dpc-2039 15 15 diagnosis diagnosis NOUN dpc-2039 15 16 of of ADP dpc-2039 15 17 necrobiotic necrobiotic ADJ dpc-2039 15 18 xanthogranuloma xanthogranuloma NOUN dpc-2039 15 19 ( ( PUNCT dpc-2039 15 20 nx nx X dpc-2039 15 21 ) ) PUNCT dpc-2039 15 22 was be AUX dpc-2039 15 23 suspected suspect VERB dpc-2039 15 24 . . PUNCT dpc-2039 16 1 a a DET dpc-2039 16 2     SPACE dpc-2039 16 3 full full ADJ dpc-2039 16 4 laboratory laboratory NOUN dpc-2039 16 5 workup workup NOUN dpc-2039 16 6 was be AUX dpc-2039 16 7 performed perform VERB dpc-2039 16 8 including include VERB dpc-2039 16 9 skin skin NOUN dpc-2039 16 10 and and CCONJ dpc-2039 16 11 bone bone NOUN dpc-2039 16 12 marrow marrow NOUN dpc-2039 16 13 biopsy biopsy NOUN dpc-2039 16 14 , , PUNCT dpc-2039 16 15 ct ct PROPN dpc-2039 16 16 scan scan NOUN dpc-2039 16 17 of of ADP dpc-2039 16 18 the the DET dpc-2039 16 19 orbital orbital ADJ dpc-2039 16 20 region region NOUN dpc-2039 16 21 and and CCONJ dpc-2039 16 22 urine urine NOUN dpc-2039 16 23 examination examination NOUN dpc-2039 16 24 . . PUNCT dpc-2039 17 1 tests test NOUN dpc-2039 17 2 revealed reveal VERB dpc-2039 17 3 an an DET dpc-2039 17 4 igg igg PROPN dpc-2039 17 5 paraproteinemia paraproteinemia NOUN dpc-2039 17 6 without without ADP dpc-2039 17 7 bone bone NOUN dpc-2039 17 8 involvement involvement NOUN dpc-2039 17 9 and and CCONJ dpc-2039 17 10 , , PUNCT dpc-2039 17 11 based base VERB dpc-2039 17 12 on on ADP dpc-2039 17 13 skin skin NOUN dpc-2039 17 14 biopsy biopsy NOUN dpc-2039 17 15 , , PUNCT dpc-2039 17 16 the the DET dpc-2039 17 17 diagnosis diagnosis NOUN dpc-2039 17 18 of of ADP dpc-2039 17 19 nx nx PROPN dpc-2039 17 20 braf braf PROPN dpc-2039 17 21 wild wild ADJ dpc-2039 17 22 type type NOUN dpc-2039 17 23 was be AUX dpc-2039 17 24 confirmed confirm VERB dpc-2039 17 25 . . PUNCT dpc-2039 18 1 figure figure VERB dpc-2039 18 2 1 1 NUM dpc-2039 18 3 . . PUNCT dpc-2039 19 1 ( ( PUNCT dpc-2039 19 2 a a X dpc-2039 19 3 ) ) PUNCT dpc-2039 19 4 clinical clinical ADJ dpc-2039 19 5 appearance appearance NOUN dpc-2039 19 6 of of ADP dpc-2039 19 7 necrobiotic necrobiotic ADJ dpc-2039 19 8 xanthogranuloma xanthogranuloma NOUN dpc-2039 19 9 showing show VERB dpc-2039 19 10 eyelid eyelid NOUN dpc-2039 19 11 and and CCONJ dpc-2039 19 12 periorbital periorbital ADJ dpc-2039 19 13 yellow yellow ADJ dpc-2039 19 14 plaques plaque NOUN dpc-2039 19 15 . . PUNCT dpc-2039 20 1 ( ( PUNCT dpc-2039 20 2 b b X dpc-2039 20 3 ) ) PUNCT dpc-2039 20 4 dermoscopic dermoscopic NOUN dpc-2039 20 5 features feature NOUN dpc-2039 20 6 of of ADP dpc-2039 20 7 xn xn PROPN dpc-2039 20 8 showing show VERB dpc-2039 20 9 yellow yellow ADJ dpc-2039 20 10 structureless structureless ADJ dpc-2039 20 11 areas area NOUN dpc-2039 20 12 that that PRON dpc-2039 20 13 correspond correspond VERB dpc-2039 20 14 to to ADP dpc-2039 20 15 the the DET dpc-2039 20 16 presence presence NOUN dpc-2039 20 17 of of ADP dpc-2039 20 18 histiocytes histiocyte NOUN dpc-2039 20 19 in in ADP dpc-2039 20 20 the the DET dpc-2039 20 21 dermis dermis NOUN dpc-2039 20 22 . . PUNCT dpc-2039 21 1 ( ( PUNCT dpc-2039 21 2 c c X dpc-2039 21 3 ) ) PUNCT dpc-2039 21 4 h&e h&e PROPN dpc-2039 21 5 histological histological ADJ dpc-2039 21 6 detail detail NOUN dpc-2039 21 7 showing show VERB dpc-2039 21 8 foamy foamy ADJ dpc-2039 21 9 histiocytes histiocyte NOUN dpc-2039 21 10 in in ADP dpc-2039 21 11 the the DET dpc-2039 21 12 dermis dermis NOUN dpc-2039 21 13 . . PUNCT dpc-2039 22 1 2 2 NUM dpc-2039 22 2 image image NOUN dpc-2039 22 3 letter letter NOUN dpc-2039 22 4 | | ADV dpc-2039 22 5 dermatol dermatol ADJ dpc-2039 22 6 pract pract NOUN dpc-2039 22 7 concept concept NOUN dpc-2039 22 8 . . PUNCT dpc-2039 23 1 2022;12(4):e2022131 2022;12(4):e2022131 NUM dpc-2039 23 2 teaching teaching NOUN dpc-2039 23 3 point point NOUN dpc-2039 23 4 necrobiotic necrobiotic ADJ dpc-2039 23 5 xanthogranuloma xanthogranuloma NOUN dpc-2039 23 6 is be AUX dpc-2039 23 7 a a DET dpc-2039 23 8 rare rare ADJ dpc-2039 23 9     SPACE dpc-2039 23 10 manifestation manifestation NOUN dpc-2039 23 11 of of ADP dpc-2039 23 12 non non ADJ dpc-2039 23 13 - - ADJ dpc-2039 23 14 langerhans langerhans ADJ dpc-2039 23 15 histiocytosis histiocytosis NOUN dpc-2039 23 16 and and CCONJ dpc-2039 23 17     SPACE dpc-2039 23 18 it it PRON dpc-2039 23 19 is be AUX dpc-2039 23 20 often often ADV dpc-2039 23 21     SPACE dpc-2039 23 22 associated associate VERB dpc-2039 23 23 with with ADP dpc-2039 23 24 monoclonal monoclonal NOUN dpc-2039 23 25 gammopathy gammopathy ADJ dpc-2039 23 26 . . PUNCT dpc-2039 24 1 references reference NOUN dpc-2039 24 2 1 1 NUM dpc-2039 24 3 . . PUNCT dpc-2039 24 4 spicknall spicknall PROPN dpc-2039 24 5 ke ke PROPN dpc-2039 24 6 , , PUNCT dpc-2039 24 7 mehregan mehregan NOUN dpc-2039 24 8 da da PROPN dpc-2039 24 9 . . PUNCT dpc-2039 24 10 necrobiotic necrobiotic ADJ dpc-2039 24 11 xanthogranuloma xanthogranuloma PROPN dpc-2039 24 12 . . PUNCT dpc-2039 25 1 int int NOUN dpc-2039 25 2 j j PROPN dpc-2039 25 3 dermatol dermatol NOUN dpc-2039 25 4 . . PUNCT dpc-2039 26 1 2009;48(1):1 2009;48(1):1 NUM dpc-2039 26 2 - - SYM dpc-2039 26 3 10 10 NUM dpc-2039 26 4 . . PUNCT dpc-2039 27 1 doi doi NOUN dpc-2039 27 2 : : PUNCT dpc-2039 27 3 10.1111 10.1111 NUM dpc-2039 27 4 / / SYM dpc-2039 27 5 j.1365 j.1365 NOUN dpc-2039 27 6 - - PUNCT dpc-2039 27 7 4632 4632 NUM dpc-2039 27 8 . . PUNCT dpc-2039 28 1 2009.03912.x 2009.03912.x NUM dpc-2039 28 2 . . PUNCT dpc-2039 29 1 pmid pmid NOUN dpc-2039 29 2 : : PUNCT dpc-2039 29 3 19126043 19126043 NUM